Alpha Lipoic Acid for Burning Mouth

This study has been completed.
Sponsor:
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00387543
First received: October 12, 2006
Last updated: April 4, 2011
Last verified: April 2011
  Purpose

Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.


Condition
Burning Sore Mouth

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Review of Mayo Clinic Experience With Burning Mouth Syndrome - Use of Alpha Lipoic Acid

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Enrollment: 200
Study Start Date: January 2000
Study Completion Date: July 2007
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   1 Year and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

records of patients diagnosed with BMS in the Department of Dermatology between 1995 and 2005

Criteria

Patients seen in the Department of Dermatology with diagnosis of burning mouth syndrome between 2000 and 2005

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00387543

Locations
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Allison J. Bruce Mayo Clinic
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00387543     History of Changes
Other Study ID Numbers: 06-002344
Study First Received: October 12, 2006
Last Updated: April 4, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Burns
Wounds and Injuries
Thioctic Acid
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protective Agents
Physiological Effects of Drugs
Vitamin B Complex
Vitamins
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on October 01, 2014